[HK]车市科技:自愿性公告 - 采纳首次公开发售後受限制股份单位计划- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]康方生物-B:自愿公告 - IL-4R单抗(AK120)获批开展治疗中重度特应性皮炎的全球II期临床研究- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]心通医疗-B:自愿公告 - 根据股份奖励计划购买股份- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]腾盛博药-B:截至二零二一年八月三十一日止之股份发行人的证券变动月报表- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]康诺亚-B:截至2021年6月30日止六个月之中期业绩公告- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]腾盛博药-B:截至2021年6月30日止六个月之中期业绩公告- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]赤子城科技:截至2021年6月30日止六个月之中期业绩公告- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]医脉通:部分行使超额配股权、稳定价格行动及稳定价格期结束- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]心通医疗-B:自愿公告 - 国家药监局批准ALWIDE PLUS心脏瓣膜球囊扩张导管的注册申请- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.